Dr. Christian Kannemeier

Senior Investment Manager

Christian joined HTGF’s Life Science team as a Senior Investment Manager in August 2023. Christian studied biology in Giessen and received his PhD in cell biology/biochemistry in collaboration with a pharmaceutical company in Marburg. Subsequently, he did postdoctoral research at the Scripps Research Institute in San Diego in the field of tumor transformation.

During his 11-year tenure with two start-up companies in California and Wisconsin, Christian led projects on the generation, differentiation, and application of human stem cells in various disease models in the drug discovery process. He has led projects on high throughput human stem cell manufacturing and the introduction of new cell-based products.

In 2018, he moved to Evotec in Hamburg, Germany, where he was able to further advance the application of stem cells in drug discovery and learn about the drug discovery processes in detail.

Portfolio

Posts & mentions

Press
4. December 2024

Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis

Investment led by Boehringer Ingelheim Venture Fund, with the participation of new and existing investors, including Apollo Health Ventures, NRW.Venture, and HTGF. New financing will accelerate preclinical development of Refoxy’s lead program in IPF as well as the expansion of its platform to additional age-related indications. Cologne, Germany, 4 December 2024 – Refoxy Pharmaceuticals GmbH is a preclinical biotech company developing small molecule activators of the
 
Press
1. February 2024

Fresh Growth Capital: Innerspace secures € 5.7 Million for Further Expansion to the USA

Financing round secures Tyrolean start-up €5.7 million for continued growth   Cooperation agreement with global industry association “PDA”  Innsbruck, 1 February 2024. The Innsbruck-based tech start-up Innerspace, which enables risk assessment of production processes and effective training of cleanroom personnel for leading pharmaceutical companies using software and Virtual Reality (VR), can advance its growth trajectory after a highly succes
 

Events

Event
2. April 2025

Med Tech Pitch Day 2025

MedTechStartups – Take your opportunity and present your technology to leading MedTech investors and corporate decision-makers. High-Tech Gründerfonds, together with B. Braun Innovation Hub, B. Braun Stiftung, Dräger, and Life Science Nord, is organizing the MEDTECH PITCH DAY 2025 on 2 April 2025 in Lübeck. You will get the opportunity to meet an exclusive audience of investors and corporates and, most importantly, experience exciting, groundbreaking pitches from medtech and healthtech star